Study: Treat-to-Target Success in Early RA Is Durable
(MedPage Today) -- Success with "treat-to-target" therapy for early-stage rheumatoid arthritis (RA) lasted up to 20 years, according to researchers who followed up with participants in two of the first clinical trials aimed at testing the strategy... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - April 4, 2024 Category: Rheumatology Source Type: news
Standard Drug Tx as Good as Stem Cell Transplant for Scleroderma?
(MedPage Today) -- Patients who underwent autologous stem cell transplantation (ASCT) for diffuse cutaneous systemic sclerosis (dcSSc), also known as scleroderma, did no better than others receiving conventional treatment, researchers found.
In... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - April 2, 2024 Category: Rheumatology Source Type: news
Predicting Vasculitis Relapse? It's SNOT That Hard
(MedPage Today) -- Scores on a patient-reported sino-nasal symptom questionnaire were associated with subsequent flares of one type of ANCA-associated vasculitis (AAV), researchers said.
Patients with granulomatosis with polyangiitis (GPA) who... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 25, 2024 Category: Rheumatology Source Type: news
Can an Autoimmunity Lead to Immune Deficiency?
(MedPage Today) -- People mounting an immune attack on interleukin-23 (IL-23) were prone to severe opportunistic infections rarely seen in the clinic, a study found.
After investigations showed that anti-IL-23 antibodies could lead to persistent... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 20, 2024 Category: Rheumatology Source Type: news
Valley Fever Screens Found Lagging for Rheum Patients in Endemic Areas
(MedPage Today) -- Medicare data indicated that most patients with rheumatologic conditions and living in areas where valley fever (aka coccidioidomycosis) is endemic were not screened for the disease before starting disease-modifying anti-rheumatic... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 14, 2024 Category: Rheumatology Source Type: news
Another Study Backs Treatment for Preclinical Rheumatoid Arthritis
(MedPage Today) -- Inflammatory markers were reduced in patients with persistent joint pain and other markers for incipient rheumatoid arthritis (RA), as was progression to formal RA diagnosis, after a 6-month course of abatacept (Orencia) in a... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 16, 2024 Category: Rheumatology Source Type: news
Senators Thrash Pharma CEOs for Pricing Drugs Higher in the U.S.
(MedPage Today) -- Senators pummeled the CEOs of three of the largest pharmaceutical companies with demands that they explain why one in four Americans can't afford their prescription drugs, prices of which are higher in the U.S. compared with... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 9, 2024 Category: Rheumatology Source Type: news
Novel Lupus Approach Yields Mixed Results in Early Trial
(MedPage Today) -- A drug engineered to "digest" extracellular RNA missed its primary endpoint in an early-stage clinical trial in systemic lupus erythematosus (SLE), though patients with higher disease activity scores did appear to show some improvement... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 8, 2024 Category: Rheumatology Source Type: news
A Clue on Why Lupus, Other Autoimmune Diseases Strike Far More Women Than Men
(MedPage Today) -- Women are far more likely than men to get autoimmune diseases, when an out-of-whack immune system attacks their own bodies -- and new research may finally explain why.
It's all about how the body handles females' extra X chromosome... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 2, 2024 Category: Rheumatology Source Type: news
Yes, Lupus Patients Can Stop MMF Treatment
(MedPage Today) -- Among patients with systemic lupus erythematosus (SLE) managed successfully with mycophenolate mofetil (MMF), rates of disease flare were not massively greater when the drug was withdrawn over several months versus kept at their... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - January 31, 2024 Category: Rheumatology Source Type: news
Could Arthritis Enhance Male Fertility?
(MedPage Today) -- Infertility does not seem to be a problem for men with inflammatory joint diseases, a large Scandinavian study indicated.
In fact, men with arthritis showed lower rates of childlessness relative to a control group, and had fathered... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - January 23, 2024 Category: Rheumatology Source Type: news
Study Slams Community Rheum Docs for Sloppy RA Management
(MedPage Today) -- Guideline recommendations for use of tumor necrosis factor (TNF) inhibitors in people with rheumatoid arthritis (RA) were only infrequently followed in independent, community-based rheumatology practices, researchers found.... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - January 18, 2024 Category: Rheumatology Source Type: news
This Biomarker Predicts Survival in Autoimmune Lung Disease
(MedPage Today) -- One major subgroup of patients with interstitial lung disease (ILD) arising from polymyositis/dermatomyositis (PM/DM) survived significantly longer when serum levels of interferon-λ3 were relatively low, researchers found... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 28, 2023 Category: Rheumatology Source Type: news
A New Test Could Save Arthritis Patients Time, Money, and Pain
(MedPage Today) -- SAN DIEGO -- Erinn Maury, MD, knew infliximab (Remicade) wasn't the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte's swollen, painful joints hadn... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 23, 2023 Category: Rheumatology Source Type: news
Axial SpA: Gender Gap Confirmed in TNF Inhibitor Response
(MedPage Today) -- Men with axial spondyloarthritis (axSpA) were more likely than women to obtain substantial relief with tumor necrosis factor (TNF) inhibitors, a multinational study indicated.
After 6 months of treatment with these agents, 66... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 15, 2023 Category: Rheumatology Source Type: news
